Keclon Overview
- Year Founded
-
2011

- Status
-
Private
- Employees
-
42

- Latest Deal Type
-
2ndary - Private
- Latest Deal Amount
-
$23.2K
- Investors
-
8
Keclon General Information
Description
Developer of biotechnological enzymes platform designed to use for biodiesel fuel production. The company's innovation platform includes product design, cell factory engineering, streamlined precision fermentation, downstream processes and from gene editing to bio-manufacturing, enabling industries to develop services based on proteins, with a highlight on enzymes and sugars to market.
Contact Information
Website
www.keclon.comCorporate Office
- Benielli 523
- San Lorenzo, Santa Fe S2200BZJ
- Argentina
Corporate Office
- Benielli 523
- San Lorenzo, Santa Fe S2200BZJ
- Argentina
Keclon Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Secondary Transaction - Private | 01-Jan-2023 | $23.2K | Completed | Product Development | ||
3. Later Stage VC | 26-Oct-2020 | Completed | Generating Revenue/Not Profitable | |||
2. Later Stage VC (Series A) | 18-Jan-2018 | $6M | $6.6M | Completed | Product Development | |
1. Seed Round | 19-Mar-2012 | $600K | $600K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Keclon Comparisons
Industry
Financing
Details
Keclon Competitors (3)
One of Keclon’s 3 competitors is Novonesis, a Corporation company based in Lyngby, Denmark.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Novonesis | Corporation | Lyngby, Denmark | ||||
Ab Enzymes (Pharmaceuticals) | Corporation | Darmstadt, Germany | ||||
DSM-Firmenich | Corporation | Kaiseraugst, Switzerland |
Keclon Patents
Keclon Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4463531-A1 | Mutated phospholipase c enzyme | Pending | 14-Jan-2022 | ||
US-10982171-B2 | Methods for oil degumming | Active | 17-Jul-2015 | ||
EP-3325630-B1 | Compositions and methods for oil degumming | Active | 17-Jul-2015 | ||
EP-3325630-A1 | Compositions and methods for oil degumming | Active | 17-Jul-2015 | ||
EP-3325630-A4 | Compositions and methods for oil degumming | Active | 17-Jul-2015 | C11B3/003 |
Keclon Signals
Keclon Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Puerto Asis Investments | Family Office | Minority | ||
Ganagrin | Corporation | Minority | ||
Molinos Agro | Corporation | Minority | ||
Santa Fe Aceites | Corporation | Minority | ||
Axia Ventures | Venture Capital | Minority |
Keclon FAQs
-
When was Keclon founded?
Keclon was founded in 2011.
-
Where is Keclon headquartered?
Keclon is headquartered in San Lorenzo, Argentina.
-
What is the size of Keclon?
Keclon has 42 total employees.
-
What industry is Keclon in?
Keclon’s primary industry is Biotechnology.
-
Is Keclon a private or public company?
Keclon is a Private company.
-
What is Keclon’s current revenue?
The current revenue for Keclon is
. -
How much funding has Keclon raised over time?
Keclon has raised $13.6M.
-
Who are Keclon’s investors?
Puerto Asis Investments, Ganagrin, Molinos Agro, Santa Fe Aceites, and Axia Ventures are 5 of 8 investors who have invested in Keclon.
-
Who are Keclon’s competitors?
Novonesis, Ab Enzymes (Pharmaceuticals), and DSM-Firmenich are competitors of Keclon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »